Sage Journals: Discover world-class research

Abstract

Bisphenol-A (BPA) is a chemical substance that is widely used in industry for manufacturing of plastic bottles and resins. Recent reports found that BPA may mimic the effects of estrogen to a great manner that might disrupt the normal hormonal balance in the human body. Fluvastatin is an agent used for treatment of hypercholesterolemia that was proven to possess promising antioxidant ant anti-inflammatory properties. Taxifolin is a polyphenolic compound with potential antioxidant and antiestrogenic effects. The present study investigated the prospect of fluvastatin with or without taxifolin to mitigate testicular dysfunction elicited by BPA in rats. In a model of BPA-induced testicular toxicity, the hormonal profile was assessed and the testicular tissues were examined by biochemical analysis, histopathology, and immunohistochemistry. Fluvastatin with or without taxifolin improved the body weight gain, hormonal profile, testicular weight and functions, sperm characteristics, the antioxidant status, and the anti-inflammatory mechanisms together with enhancement of autophagy and suppression of the proapoptotic events induced by BPA in the testicular tissues. In addition, fluvastatin with or without taxifolin significantly mitigated the histopathological and the immunohistochemical changes induced by BPA in the testicular tissues. These desirable effects were more pronounced with fluvastatin/taxifolin combination relative to the use of each of these agents alone. In tandem, fluvastatin/taxifolin combination might counteract the pathogenic events induced by BPA in the testicular tissues which may be considered as a novel strategy for amelioration of these disorders.

Keywords

bisphenol-A fluvastatin taxifolin autophagy apoptosis testis

Introduction

Bisphenol-A (BPA) is a synthetic diphenylmethane derivative that is used for the manufacturing of certain types of plastics and resins that represent the containers that store a wide range of foods and beverages.¹ BPA is considered as one of the highest volume of chemicals produced and used all over the world, particularly in the water bottles.² Recent reports paid the attention towards the findings that chronic exposure to BPA may cause endocrinal dysfunction.^3,4 These findings might be attributed to the close similarity between the phenol groups in both BPA and estradiol, which may confer an effect to BPA on the estrogenic pathways in the body.⁵ In addition, high concentrations of BPA were proven to block the androgen receptors (AR), modulate Leydig cell steroidogenesis, and hinder LH receptor-ligand binding.⁴ Also, massive generation of reactive oxygen species (ROS) induced by BPA with subsequent apoptotic changes associated with suppression of autophagy were proposed as possible underlying mechanisms.⁶ Together, these effects attracted the attention of the authorities to the possible reproductive toxicity induced by BPA.⁷

Fluvastatin is one of the agents that restore the normal serum cholesterol levels in cases of hypercholesterolemia.⁸ Recent trials postulated that fluvastatin has the ability to clean hydroxyl and superoxide radicals from the body and augment the antioxidant defense mechanisms.⁹ In addition, fluvastatin was proven to modulate the mammalian target of rapamycin (mTOR) signaling pathway in a manner that may significantly ameliorate toxin-induced testicular damage.¹⁰ Moreover, fluvastatin was proposed as a potentially vital agent that restores the balance between the pro-apoptotic and the anti-apoptotic proteins which is usually lost in toxin-induced gonadal dysfunction.¹¹

Taxifolin is a flavonoid that was proven to have potent radical scavenging activities in various tissues of the body.¹² Taxifolin was reported to have endogenous antioxidant properties which may enhance the activity of the antioxidant enzymes and ameliorate the deleterious effects of the different types of ROS on body tissues.¹³ In addition, the proven effects of taxifolin on the inflammatory and the apoptotic pathways together with its anti-estrogenic effects may make it a potential candidate for amelioration of BPA-induced testicular dysfunction.¹⁴ The main target of the present trial was to investigate the prospect of fluvastatin with or without taxifolin to mitigate the testicular dysfunction elicited by BPA in rats.

Materials and methods

Chemicals and reagents

BPA was supplied by Sigma Aldrich Co., USA (CAS # 80-05-7). Fluvastatin was provided by a commercial vendor (Cayman Chemical, Michigan, USA; CAS # 93957-54-1). Taxifolin and methyl cellulose were obtained from Santa Cruz Biotechnology, Heidelberg, Germany (CAS # 480-18-2 and 9004-65-3, respectively). The other reagents were supplied as a kind gift from RayBiotech, GA, USA and were of analytical grade. BPA was dissolved in olive oil. Fluvastatin and taxifolin were administered as a suspension in 1% methyl cellulose solution.

Experimental animals

The present study was conducted using 48 male 8-weeks old Wistar rats, weighing about 170–230 g. Rats had unrestricted access to the lab food and drinking water, under experimental conditions of 12 L/12D lighting system, with humidity of 55–68%, and temperature of 22–25°C throughout the experiment. Rats were allowed to acclimatize for 10 days before starting the experimental procedures. This study was approved by the Research Ethics Committee of Faculty of Medicine, Tanta University, Egypt (Approval code 33516/8). Animal handling was carried out by strictly following Helsinki declaration of animal ethics.

Experimental protocol

Animals were randomly divided into six equal groups of eight rats per group by a technician who was unaware of the identity of the experimental groups as follows: I) Control group, received 0.5 mL olive oil daily by oral gavage; II) BPA group, received BPA in a dose of 20 μg/kg by oral gavage¹⁵; III) BPA + methyl cellulose group, received 1% methyl cellulose solution concomitantly with BPA by oral gavage; IV) BPA + Fluvastatin group, received fluvastatin (10 mg/kg/day) by oral gavage¹⁶ concomitantly with BPA; V) BPA + Taxifolin group, received taxifolin (50 mg/kg/day) by oral gavage¹⁷ concomitantly with BPA, and VI) BPA + Fluvastatin + Taxifolin group, received BPA, fluvastatin, and taxifolin in the fore-mentioned doses by oral gavage. Olive oil, BPA, methyl cellulose, fluvastatin, and taxifolin were given daily for 8 weeks. Body weight was measured at the start of the study and then every 7 days throughout the whole study.

Harvesting the blood and tissue samples

At the end of the experimental period, blood samples were obtained from the retro-orbital plexus, centrifuged and the sera were used for measurement of the hormonal profile. After animal euthanization, both testes from each rat were dissected and washed with saline. The right testes were weighed and kept at –80°C for further homogenization and assay of the biochemical measurements. The left testes were put in 10% formol-buffered saline (pH 7.4) for further histopathological and immunohistochemical assay.

Measurement of the hormonal profile

Serum follicle-stimulating hormone (FSH) was assayed using kits supplied by Elabscience, Texas, USA (CAT # E-EL-R0391). Also, ELISA kits produced by CUSABIO, Houston, TX, USA (CAT # CSB-E12654r) were utilized for measurement of serum luteinizing hormone (LH) levels according to the vendor’s protocol. In addition, kits purchased from Boster Biological Technology, Pleasanton, USA (CAT # EK7014) were used for assessment of serum levels of testosterone according to the vendor’s instructions. Following the manufacturer’s guide, assay of tissue 3-beta hydroxysteroid dehydrogenase type 1 (HSD3B1) and 17-beta hydroxysteroid dehydrogenase 1 (HSD17B1) was executed using kits purchased from MyBioSource, San Diego, USA (CAT # MBS456446 and HSD17B1, respectively).

Assay of the markers of the testicular functions

Tissue lactate dehydrogenase (LDH) was assayed using ELISA kits (CAT # MBS2018912, MyBioSource, San Diego, USA). The levels of alkaline phosphatase (ALP) and glucose-6-phosphate dehydrogenase (G6PD) activity were determined using kits purchased from BioVision, Milpitas, USA (CAT # E4575-100 and K757-100, respectively). ELISA kits supplied by AssayGenie, Dublin, Ireland (CAT # RTFI01238) were utilized for detection of tissue acid phosphatase (ACP). Assay of the markers of the testicular functions was performed as instructed by the vendor.

Assay of the antioxidant enzymes, nuclear factor erythroid 2-related factor 2 (Nrf2), and heme oxygenase-1 (HO-1) content in the testicular tissues

For assessment of the antioxidant status of the testicular tissues, kits supplied by MyBioSource, San Diego, USA (CAT # MBS726781 and MBS9308239) were utilized for measurement of tissue catalase (CAT) and glutathione reductase (GR), respectively, according to the vendor’s instructions. Nrf2 content of the testicular tissues was quantified using kits purchased from Novus Biologicals, USA (CAT # NBP3-08161) following the manufacturer’s guide. The vendor’s instructions of the kits supplied by CUSABIO, USA (CAT # CSB-E08267r) were followed to determine HO-1 content in the testicular tissues.

Assay of transforming growth factor beta 1 (TGF-β1), interleukin 8 (IL-8), interleukin 18 (IL-18), and nucleotide-binding domain-like receptor family, pyrin domain-containing 3 (NLRP3) inflammasome in the testicular tissues

TGF-β1 levels were assayed using kits obtained from ThermoFisher Scientific, USA (CAT # BMS623-3). ELISA kits purchased from ABclonal, Woburn, MA, USA (CAT # ERI0063 and RK03757) were used to conduct assay of IL-8 and IL-18, respectively, following the vendor’s instructions. The levels of NLRP3 inflammasome were measured using kits provided by Abcam, USA (CAT # ab277086) according to the guidelines of the manufacturer.

Determination of testicular tissue phospho-mTOR, phosphoprotein kinase B (p-AKT), p38 mitogen-activated protein (p-MAP) kinase and beclin-1 levels

Phospho-mTOR levels were quantified using kits supplied by Cell Signaling, USA (CAT # 7976) with strict adherence to the provider’s guide. P-AKT was measured in the testicular tissues with the aid of ELISA kits (RayBiotech, USA, CAT # PEL-AKT-S473-T-1) according to the vendor’s instructions. ELISA kits purchased from MyBioSource, San Diego, USA (CAT # MBS720509 and MBS733192) was used to detect the levels of tissue p38 MAP kinase and beclin-1, respectively, following the provider’s instructions.

Assay of the apoptotic markers in the testicular tissues

Caspase 3, Bax, and Bcl-2 in the testicular tissues were quantified using kits supplied by MyBioSource, USA (CAT # MBS018987, MBS935667 and MBS2881713, respectively) according to the protocol provided by the vendor.

Determination of the characteristics of the spermatozoa

The epididymis was sliced in 5 mL of Ham’s F10 and incubated for 5 min at 37°C in 5% CO₂. This allows the sperms to swim out of the epididymal tubules. Immediately after that, one drop of the suspension was placed on a glass slide with a cover slip and the percentage of the motile sperms was counted microscopically within 2–4 min of their isolation using 10 microscopic fields at ×400 magnification.¹⁸

The number of the epididymal sperms was counted by following the method of Wang.¹⁹ Also, smears of the epididymal suspension were prepared on glass slides and left to dry overnight, after which they were stained with 1% eosin-Y/5% nigrosine. Then, these slides were examined at 400× for detection of the morphological abnormalities of the spermatozoa.²⁰

Histopathological evaluation of the testicular tissues

The left testes were immersed in 10% formalin solution for 24 h, dehydrated in ethanol then embedded in paraffin. After that, tissue sections were cut, put on glass slides, stained with hematoxylin and eosin and inspected using the light microscope. Spermatogenesis was assessed using Johnsen’s²¹ tubular biopsy score (JTBS). Also, seminiferous tubules diameter (STD) and the thickness of the germinal epithelium were evaluated according to Erfani Majd et al.²² under a light microscope (Olympus Optical Co., Japan) using Image J Software (1.49v), NIH, USA.

Evaluation of the expression of Ki-67 in the testicular tissues

Five μm sections of the left testes were dewaxed, then rehydrated in xylene and distilled water. Then, retrieval of the antigen was executed in a microwave oven. Endogenous peroxidase activity was quenched by 3% hydrogen peroxide solution at 25°C for 30 min. After that, these sections were blocked using 5% bovine serum for 15 min. Then, sections were incubated with specific primary antibodies against Ki-67 (GB11010; Wuhan Saiweier Biological Technology, China, dilution 1:100) overnight at 4°C in a humidified chamber. Then, sections were washed and incubated with secondary antibody, and stained by 3, 3^′-diaminobenzidine. After that, sections were counterstained with hematoxylin and rinsed in tap water. The labeled sections were examined by a light microscope at a magnification of ×10 to detect areas with obvious Ki-67 staining. In every section, the most intense three areas stained with Ki-67 were detected and the ratio of the number of the nuclei positively stained with Ki-67 antigen was counted in each area using Image-J software (1.49v), NIH, USA. The average of these ratios indicated the degree of positive Ki-67 immunostaining.²³

Statistical analysis of the results

Analysis of the obtained results was carried out using GraphPad Software version 6.04 for Science Inc., CA, USA. Shapiro-Wilk test was utilized for examination of the parametric data. The statistical significance among the different groups was assessed by one-way analysis of variance (ANOVA) and Tukey’s test (Significant at p-value less than 0.05). The obtained data were presented as mean ± standard deviation (SD).

Results

Fluvastatin and/or taxifolin improved the body weight gain in BPA-treated animals

Significant decrease in the final body weight (0.35-fold change) was noted in rats treated with BPA relative to the control group. This decrease was not improved with administration of methyl cellulose but treatment with either fluvastatin or taxifolin improved the final body weight (1.17- and 1.21-fold change, respectively) versus animals treated with BPA alone. This improvement was significant with fluvastatin/taxifolin combination relative to treatment with either fluvastatin or taxifolin alone (1.16- and 1.13-fold change, respectively) (Figure 1).

Figure 1.

Fluvastatin with or without taxifolin affects the body weight gain in bisphenol-A treated animals (Mean ± SD). (a) Significant versus the control group (p-value less than 0.05), (b) Significant versus bisphenol-A group (p-value less than 0.05), (c) Significant versus bisphenol-A + Fluvastatin group (p-value less than 0.05), and (d) Significant versus bisphenol-A + Taxifolin group (p-value less than 0.05).

Fluvastatin and/or taxifolin combatted the hormonal changes induced by BPA

Significant decline in serum testosterone, LH, and FSH (0.64-, 0.45-, and 0.52-fold change, respectively) associated with significant decrease in tissue levels of HSD3B1 and HSD17B1 (0.56- and 0.57-fold change, respectively) were noted in animals that received BPA versus the control group. These changes were not significantly affected with addition of methyl cellulose. Addition of fluvastatin and/or taxifolin significantly combatted these changes with restoration of the hormonal levels to the normal values. This effect was maximal with fluvastatin/taxifolin combination group versus animals that received each of these agents alone (Table 1).

Table 1.

Effect of fluvastatin with or without taxifolin on the hormonal profile in bisphenol-A treated animals (mean ± SD).

	Control	Bisphenol-A	Bisphenol-A + Methyl cellulose	Bisphenol-A + Fluvastatin	Bisphenol-A + Taxifolin	Bisphenol-A + Fluvastatin + Taxifolin
Serum testosterone (ng/dl)	210.3 ± 22.7	75.6 ± 8.79^a	80.2 ± 9.03	132.78 ± 14.9^b	120.56 ± 12.6^b	171.2 ± 18.31^b,c,d
Serum LH (mIU/ml)	0.51 ± 0.06	0.28 ± 0.03^a	0.24 ± 0.03	0.39 ± 0.04^b	0.35 ± 0.03^b	0.46 ± 0.05^b,c,d
Serum FSH (mIU/ml)	0.23 ± 0.03	0.11 ± 0.01^a	0.09 ± 0.01	0.15 ± 0.02^b	0.14 ± 0.01^b	0.19 ± 0.02^b,c,d
Tissue HSD3B1 (nmol of NAD reduced/min/mg protein)	2.83 ± 0.29	1.24 ± 0.13^a	1.15 ± 0.12	2.14 ± 0.22^b	1.98 ± 0.21^b	2.51 ± 0.27^b,c,d
Tissue HSD17B1 (nmol of NAD reduced/min/mg protein)	0.28 ± 0.03	0.12 ± 0.01^a	0.13 ± 0.02	0.19 ± 0.02^b	0.17 ± 0.02^b	0.24 ± 0.03^b,c,d

^aSignificant versus the control group (p-value less than 0.05).

^bSignificant versus bisphenol-A group (p-value less than 0.05).

^cSignificant versus bisphenol-A + Fluvastatin group (p-value less than 0.05).

^dSignificant versus bisphenol-A + Taxifolin group (p-value less than 0.05).

Fluvastatin and/or taxifolin restored the markers of testicular functions to the normal values compared to PBA-treated animals

Significant decline in LDH, ALP, ACP, and G6PD (0.49-, 0.48-, 0.43- and 0.45-fold change, respectively) was noticed in the samples taken from the testicular tissues of rats treated with BPA alone versus the control group. No significant changes in these markers were observed after addition of methyl cellulose. However, fluvastatin and/or taxifolin were able to combat these changes with significant increase in these markers compared to animals that received BPA alone but fluvastatin/taxifolin combination exhibited the maximal improvement (Table 2).

Table 2.

Effect of fluvastatin with or without taxifolin on the testicular function tests in bisphenol-A treated animals (mean ± SD).

	Control	Bisphenol-A	Bisphenol-A + Methyl cellulose	Bisphenol-A + Fluvastatin	Bisphenol-A + Taxifolin	Bisphenol-A + Fluvastatin + Taxifolin
Tissue LDH (U/mg protein)	5.59 ± 0.68	2.83 ± 0.37^a	2.74 ± 0.34	3.96 ± 0.47^b	3.64 ± 0.42^b	4.82 ± 0.6^b,c,d
Tissue ALP (U/mg protein)	162.12 ± 18.89	83.71 ± 10.12^a	80.48 ± 9.86	114.8 ± 13.83^b	102.36 ± 11.97^b	138.7 ± 15.6^b,c,d
Tissue G6PD activity (nmol/min/ml)	6.48 ± 0.77	3.56 ± 0.42^a	3.67 ± 0.48	5.02 ± 0.63^b	4.71 ± 0.57^b	5.89 ± 0.69^b,c,d
Tissue ACP (U/mg protein)	145.64 ± 16.13	83.47 ± 9.63^a	79.4 ± 8.92	103.38 ± 11.84^b	95.91 ± 10.93^b	123.56 ± 14.3^b,c,d

^aSignificant versus the control group (p-value less than 0.05).

^bSignificant versus bisphenol-A group (p-value less than 0.05).

^cSignificant versus bisphenol-A + Fluvastatin group (p-value less than 0.05).

^dSignificant versus bisphenol-A + Taxifolin group (p-value less than 0.05).

Fluvastatin and/or taxifolin improved the antioxidant status and mitigated the changes in Nrf2/HO-1 content in BPA-treated animals

Administration of BPA elicited significant decrease in tissue CAT, GR, Nrf2, and HO-1 (0.45-, 0.47-, 0.51- and 0.56-fold change, respectively) in the testicular tissues versus the control group. Methyl cellulose didn’t significantly affect these parameters compared to animals that received BPA alone. These changes were reversed in the groups treated with fluvastatin and/or taxifolin but rats treated with fluvastatin/taxifolin combination exhibited maximal improvement relative to groups treated with each of these agents alone (Figure 2).

Figure 2.

Effect of fluvastatin with or without taxifolin on tissue antioxidant enzymes and Nrf2/HO-1 content in bisphenol-A treated animals (Mean ± SD). (a) Significant versus the control group (p-value less than 0.05), (b) Significant versus bisphenol-A group (p-value less than 0.05), (c) Significant versus bisphenol-A + Fluvastatin group (p-value less than 0.05), and (d) Significant versus bisphenol-A + Taxifolin group (p-value less than 0.05).

Fluvastatin and/or taxifolin abrogated the changes related to the inflammatory cascade induced by BPA in the testicular tissues

The values of TGF-β1, IL-8, IL-18, and NLRP3 inflammasome were significantly elevated (4.3-, 9.5-, 3.89-, and 3.3-fold change, respectively) in the testicular tissues of rats treated with BPA versus the control group. These values were kept elevated even after administration of methyl cellulose. However, significant decline in the tissue levels of these parameters were observed with addition of either fluvastatin or taxifolin compared to the group treated with BPA alone. Interestingly, this decline was significant with fluvastatin/taxifolin combination comparable to animals treated with each of these agents alone (Table 3).

Table 3.

Effect of fluvastatin with or without taxifolin on the inflammatory markers in bisphenol-A treated animals (mean ± SD).

	Control	Bisphenol-A	Bisphenol-A + Methyl cellulose	Bisphenol-A + Fluvastatin	Bisphenol-A + Taxifolin	Bisphenol-A + Fluvastatin +Taxifolin
Tissue IL-8 (pg/mg protein)	32.4 ± 4.3	308.7 ± 36.23^a	315.6 ± 38.14	219.7 ± 25.17^b	242.6 ± 27.8^b	159.4 ± 18.81^b,c,d
Tissue IL-18 (pg/mg protein)	135.2 ± 14.5	538.6 ± 58.73^a	519.8 ± 53.47	388.1 ± 40.22^b	422.7 ± 46.5^b	289.4 ± 30.13^b,c,d
Tissue TGF-β1 (pg/mg protein)	42.15 ± 4.63	181.2 ± 19.34^a	169.37 ± 17.25	113.92 ± 12.09^b	131.6 ± 13.7^b	86.48 ± 9.22^b,c,d
NLRP3 inflammasome (pg/mg protein)	124.89 ± 13.7	415.8 ± 43.82^a	402.54 ± 42.6	314.75 ± 33.2^b	335.8 ± 34.1^b	265.18 ± 28.4^b,c,d

^aSignificant versus the control group (p-value less than 0.05).

^bSignificant versus bisphenol-A group (p-value less than 0.05).

^cSignificant versus bisphenol-A + Fluvastatin group (p-value less than 0.05).

^dSignificant versus bisphenol-A + Taxifolin group (p-value less than 0.05).

Fluvastatin and/or taxifolin enhanced the autophagy-associated pathways in the testicular tissues of the studied groups

Administration of BPA resulted in marked suppression of autophagy manifested by significant decrease in tissue p38 MAPK and beclin-l (0.6- and 0.54-fold change, respectively) with significant increase in tissue p-mTOR and p-AKT levels (1.82- and 1.93-fold change, respectively) compared versus the control group. Treatment of BPA group with methyl cellulose didn’t significantly affect the levels of these parameters compared to animals treated with BPA alone. Each of fluvastatin or taxifolin significantly enhanced autophagy manifested by significant elevation of p38 MAPK and beclin-l accompanied with significant abrogation of p-mTOR and p-AKT compared to animals treated with BPA alone but the maximal enhancement of autophagy was accomplished in rats treated with fluvastatin/taxifolin combination (Table 4).

Table 4.

Effect of fluvastatin with or without taxifolin on testicular tissue phosphorylated AKT, mTOR, p38 MAP kinase, and beclin-1 levels in bisphenol-A treated animals (mean ± SD).

	Control	Bisphenol-A	Bisphenol-A + Methyl cellulose	Bisphenol-A + Fluvastatin	Bisphenol-A + Taxifolin	Bisphenol-A + Fluvastatin +Taxifolin
Tissue p-AKT (% change from the control)	100.00	193.44 ± 20.1^a	185.12 ± 19.43	161.43 ± 17.7^b	167.63 ± 17.9^b	142.3 ± 15.41^b,c,d
Tissue p-mTOR (% change from the control)	100.00	182.78 ± 19.82^a	176.8 ± 18.12	145.41 ± 15.88^b	154.37 ± 16.2^b	126.12 ± 13.05^b,c,d
Tissue p38 MAPK (% change from the control)	100.00	60.13 ± 7.82^a	63.92 ± 7.33	79.14 ± 8.02^b	75.13 ± 7.91^b	89.23 ± 9.13^b,c,d
Tissue beclin-1 (ng/g protein)	8.15 ± 1.04	3.72 ± 0.43^a	3.54 ± 0.39	6.04 ± 0.66^b	5.58 ± 0.61^b	6.94 ± 0.73^b,c,d

^aSignificant versus the control group (p-value less than 0.05).

^bSignificant versus bisphenol-A group (p-value less than 0.05).

^cSignificant versus bisphenol-A + Fluvastatin group (p-value less than 0.05).

^dSignificant versus bisphenol-A + Taxifolin group (p-value less than 0.05).

Fluvastatin and/or taxifolin significantly combatted the apoptotic changes induced by BPA in the testicular tissues

Animals treated with fluvastatin or taxifolin exhibited significant suppression of apoptosis evidenced by significant decrease in caspase-3 (0.34- and 0.24-fold change, respectively) and Bax (0.27- and 0.21-fold change, respectively) with significant increase in Bcl-2 levels (1.38- and 1.3-fold change, respectively) in the testicular tissues when compared to animals treated with BPA alone. The maximal inhibition of apoptosis was evidenced in rats that received fluvastatin/taxifolin combination. However, methyl cellulose didn’t exhibit any antiapoptotic effects when administered to BPA-treated rats (Figure 3).

Figure 3.

Effect of fluvastatin with or without taxifolin on caspase-3, Bax, and Bcl-2 levels in the testicular tissues of bisphenol-A treated animals (Mean ± SD). (a) Significant versus the control group (p-value less than 0.05), (b) Significant versus bisphenol-A group (p-value less than 0.05), (c) Significant versus bisphenol-A + Fluvastatin group (p-value less than 0.05), and (d) Significant versus bisphenol-A + Taxifolin group (p-value less than 0.05).

Fluvastatin and/or taxifolin mitigated the changes in the characteristics of the spermatozoa induced by BPA

Significant decrement in the sperm count and motility (0.37- and 0.42-fold change, respectively) with significant elevation in the proportion of the dead and abnormally formed sperms (3.01- and 2.5-fold change, respectively) were noticed in rats treated with BPA alone compared to the control. Methyl cellulose didn’t elicit any significant improvement of these characteristics versus rats treated with BPA alone. Fluvastatin and/or taxifolin significantly combatted these changes with significant increase in the sperm count and motility with significant decrement in the proportion of the dead and abnormally formed sperms when compared to the group treated with BPA alone but fraxetin/taxifolin combination had the upper hand (Table 5).

Table 5.

Effect of fluvastatin with or without taxifolin on the sperm characteristics in bisphenol-A treated animals (mean ± SD).

	Control	Bisphenol-A	Bisphenol-A + Methyl cellulose	Bisphenol-A + Fluvastatin	Bisphenol-A + Taxifolin	Bisphenol-A + Fluvastatin + Taxifolin
Sperm count (x10⁶/mL)	163.74 ± 18.85	103.56 ± 12.45^a	109.12 ± 12.21	136.31 ± 16.2^b	125.4 ± 14.76^b	152.6 ± 17.11^b,c,d
Motility (%)	72.43 ± 8.68	42.12 ± 5.41^a	40.8 ± 5.03	54.39 ± 6.15^b	49.52 ± 5.89^b	66.48 ± 7.69^b,c,d
Dead sperms (%)	8.12 ± 0.91	24.6 ± 2.82^a	26.1 ± 2.97	18.03 ± 1.97^b	20.2 ± 2.52^b	11.83 ± 1.25^b,c,d
Abnormal sperms (%)	7.48 ± 0.82	18.73 ± 1.97^a	19.02 ± 2.06	12.86 ± 1.34^b	13.62 ± 1.45^b	8.84 ± 0.96^b,c,d

^aSignificant versus the control group (p-value less than 0.05).

^bSignificant versus bisphenol-A group (p-value less than 0.05).

^cSignificant versus bisphenol-A + Fluvastatin group (p-value less than 0.05).

^dSignificant versus bisphenol-A + Taxifolin group (p-value less than 0.05).

Fluvastatin and/or taxifolin combatted the changes in the testicular morphometric characteristics and JTBS induced by BPA

Rats that received BPA alone exhibited significant decrease in the testicular weight, GET, STD, and JTBS (0.55-, 0.47-, 0.45-, and 0.52-fold change, respectively) compared to the control group (Table 6). This was accompanied with widespread loss of the testicular architecture with increased cytoplasmic vacuolization in the spermatogenic cells in addition to shrinkage and fragmentation of their nuclei. Moreover, massive areas of coagulative necrosis appeared in the seminiferous tubules with widespread absence of the spermatogenic cells, interstitial edema, and extensive vascular congestion (Figure 4(b)). Administration of methyl cellulose didn’t elicit any changes in the histopathological picture when compared to BPA group (Table 6, Figure 4(c)). Either fluvastatin or taxifolin significantly restored the normal testicular morphometric measurements (Table 6) with abrogation of the above-mentioned structural changes induced by BPA in the spermatogenic cells and the seminiferous tubules (Figures 4(d) and (e)). Interestingly, animals treated with fluvastatin/taxifolin combination exhibited apparently normal testicular morphometric measurements with significant improvement of the histopathological changes versus the animal groups treated with each of these agents alone (Table 6, Figure 4(f)).

Table 6.

Effect of fluvastatin with or without taxifolin on the testicular morphometric characteristics and Johnsen’s tubular biopsy score (JTBS) in bisphenol-A treated animals (mean ± SD).

	Control	Bisphenol-A	Bisphenol-A + Methyl cellulose	Bisphenol-A + Fluvastatin	Bisphenol-A + Taxifolin	Bisphenol-A + Fluvastatin + Taxifolin
Testicular weight (g)	1.53 ± 0.17	0.69 ± 0.08^a	0.73 ± 0.08	1.14 ± 0.12^b	0.98 ± 0.11^b	1.33 ± 0.14^b,c,d
Thickness of the germinal epithelium (GET)	89.34 ± 10.2	47.24 ± 6.02^a	45.17 ± 5.96	65.84 ± 8.22^b	59.61 ± 7.66^b	74.39 ± 9.03^b,c,d
Diameter of seminiferous tubules (STD)	252.4 ± 29.85	139.5 ± 16.43^a	143.4 ± 17.85	189.8 ± 21.23^b	177.3 ± 19.93^b	221.8 ± 25.64^b,c,d
JTBS	8.98 ± 1.04	4.33 ± 0.57^a	4.19 ± 0.51	6.16 ± 0.78^b	5.73 ± 0.69^b	7.55 ± 0.87^b,c,d

^aSignificant versus the control group (p-value less than 0.05).

^bSignificant versus bisphenol-A group (p-value less than 0.05).

^cSignificant versus bisphenol-A + Fluvastatin group (p-value less than 0.05).

^dSignificant versus bisphenol-A + Taxifolin group (p-value less than 0.05).

Figure 4.

Hematoxylin and eosin-stained specimens of the testicles (x200) of (a) Control group with normal structure of the testis with well-formed seminiferous tubules which contain layers of the spermatogenic cells and spermatozoa, (b) Bisphenol A (BPA) treated group showing loss of the spermatogenic cells from the seminiferous tubules with detachment of some of them in the lumen (Arrow head). The interstitial tissue shows coagulative necrosis (Thick arrow) with severe vascular congestion (Thin arrow), (c) BPA + methyl cellulose group showing dilated empty lumen of most seminiferous tubules with cellular detachment in the lumen (Arrow head), profuse vascular congestion (Thin arrow) and coagulative necrosis of the interstitium (Thick arrow), (d) BPA + Fluvastatin group exhibiting significant decrement of the coagulative necrosis (Thick arrow) and vascular congestion (Thin arrow) of the interstitium with most seminiferous tubules showing well organized spermatogenic cells (Arrow head), (e) BPA + taxifolin group with significant improvement in the architecture of the seminiferous tubules (Arrow head) with significant decrease in the vascular congestion (Thin arrow) and scanty areas of coagulative necrosis of the interstitial tissue (Thick arrow), and (f) BPA + fluvastatin + taxifolin group exhibiting apparently normal testicular architecture with well-formed seminiferous tubules (Arrow head) and interstitium (Thick arrow) with significant diminution of vascular congestion (Thin arrow).

Fluvastatin and/or taxifolin mitigated the increase in Ki-67 immunoexpression induced by BPA in the testicular tissues

Significant increase in Ki-67 immunoexpression was noticeable in BPA-treated group relative to the control group (Figures 5(a) and (b)). Addition of methyl cellulose didn’t significantly affect Ki-67 immunoexpression versus animals treated with BPA alone (Figure 5(c)). Administration of either fluvastatin or taxifolin to BPA-treated rats resulted in significant increment of Ki-67 immunostaining compared versus rats treated with BPA alone (Figures 5(d) and (e)) but fluvastatin/taxifolin combination group exhibited the maximal inhibition of Ki-67 immunoexpression (Figure 5(f)).

Figure 5.

Immunohistochemical staining for Ki-67 of testicular specimens from (a) The control group exhibiting absence of immunostaining of Ki-67, (b) BPA group showing markedly positive immunostaining of Ki-67 (+++), (c) BPA group treated with methyl cellulose with markedly positive immunostaining of Ki-67 (+++), (d) BPA group treated with fluvastatin exhibiting moderate positive immunostaining of Ki-67 (++), (e) BPA group treated with taxifolin revealing moderate positive immunoexpression of Ki-67 (++), and (f) BPA group treated with fluvastatin/taxifolin combination exhibiting mild positive immunoexpression of Ki-67 (+).

Discussion

In the last decades, diphenylmethane derivatives attained an increasing importance for the industry of certain types of plastics and resins.²⁴ Among these derivatives, recent studies were directed towards BPA which is a synthetic organic substance which is the precursor of certain polycarbons and epoxy resins that are used for the manufacturing of the plastic containers of foods and drinks.²⁵ Interestingly, some recent trials aroused the attention towards the toxic effects of the long use of BPA on the testicular functions.²⁶ This hypothesis relied on the finding that BPA is a xenoestrogen that may exert estrogen-mimicking effects.⁴ These effects together with the pro-oxidant, proinflammatory, and apoptosis promoting properties of BPA might induce deleterious effects on the testicular microenvironment which in turn may significantly affect the reproductive functions in males.²⁷ This was in accordance with the data obtained from the present study where BPA elicited significant decrease in the body weight gain, the testicular morphometric measurements and the markers of testicular functions. This was accompanied with significant decrease in serum testosterone, LH, FSH, HSD3B1, and HSD17B1 secretion and markedly affected the sperm characteristics and the histopathological picture when compared versus the control group.

The balance between the pro-oxidant and the antioxidant factors was reported to play a fundamental role in the testicular toxicity induced by BPA.²⁸ Coinciding with the results of the present work, Rahman and Pang.²⁹ stated that ROS generated by BPA in the testicular tissues have a detrimental effect on the spermatogenic functions of the testis, thus inducing reproductive dysfunction. BPA was found to repress the main enzymes responsible for the antioxidant defense mechanisms in the testicular tissues.²⁸ In addition, BPA was reported to enhance the generation of free radicals, which in turn will decrease Nrf2 content and attenuate the activity of HO-1 in the testicular tissues with the end result of deprivation of the testis from an important defense mechanism against oxidative stress.³⁰

In the present work, rats treated with fluvastatin/BPA combination exhibited significant improvement of the activity of the antioxidant enzymes with restoration of Nrf2/HO-1 content of the testicular tissues when compared versus rats treated with BPA alone. This was explained by Gurel et al.¹⁰ who proved that fluvastatin has detrimental effects on the pro-oxidant/antioxidant pathways in the testicular tissues. Ramanjaneyulu et al.³¹ reported a significant increase in the total antioxidant capacity together with significant decline in malondialdehyde levels in the testicular tissues with administration of statins. These effects may be explained by the well documented effects of fluvastatin on Nrf2/HO-1 pathway which subsequently affect the activity of the antioxidant enzymes at the gene expression levels.³² Interestingly, taxifolin in the present study was able to restore the antioxidant enzyme levels and mitigate the decremental effect of BPA on Nrf2/HO-1 content of the testicular tissues. This was confirmed by the well-proven antioxidant effects of taxifolin which were attributed in a large proportion to its free radical scavenging and singlet oxygen quenching mechanisms.³³

Recent reports threw light on the role of NLRP3 inflammasome in the pathogenic events that take place in the testicular tissue as a consequence of BPA administration.²⁸ Wang et al.³⁴ stated that ROS generated by BPA enhance the binding of danger-associated proteins to toll-like receptor 4 (TLR4). It is evident that generation of the intracellular ROS activates nuclear factor kappa B (NF-κB), TGF-β1, and caspase three followed by alteration of the Bax/Bcl-2 ratio to cause systemic damage in rat model; such condition ultimately leads to inflammation and apoptosis.^35,36 Enhancement of the activity of NF-κB/TGF-β1 signaling pathways consequently upregulates the transcription of NLRP3 inflammasome.³⁷ This in turn was suggested to promote the proteolytic cleavage of pro-IL-8 and pro-IL-18 resulting in propagation of the inflammatory process in the testicular tissues and induction of apoptosis.³⁸ This coincided with the data obtained from the present study where BPA induced significant increase in TLR4 and NLRP3 inflammasome expression with subsequent increase in the inflammatory mediators including TGF-β1, IL-8, and IL-18 relative to the corresponding levels in the control group. This was also evidenced by the changes of the histopathological picture of the testicular tissues which were subjected to massive inflammatory cellular infiltration.

An interesting finding in the present study was that fluvastatin administration elicited a mitigating effect on the expression of NLRP3 inflammasome which subsequently abrogated the inflammatory cascade and combatted the expression of the proapoptotic proteins. This was attributed by Wang et al.³⁹ to the inhibitory effects of statins on the production of ROS which consequently deprives the NF-κB/TGF-β1 signaling pathway from an important triggering factor. Also, fluvastatin was proven to activate peroxisome proliferator activated receptor gamma (PPAR-γ) which plays a fundamental role in regulation of NLRP3 expression and modulation of the inflammatory process.⁴⁰

The present data strongly established an important link between NLRP3 expression and the anti-inflammatory effects of taxifolin on the testicular tissues. Ponte et al.⁴¹ stated that taxifolin may modulate the expression of NF-κB and decrease TLR4 levels, which in turn decrease the tissue levels of NLRP3 inflammasome. In addition, taxifolin was found to combat the binding of danger-associated proteins to TLR4 which subsequently deprives NLRP3 inflammasome from an important step in the pathway of its activation.^42,43 Moreover, taxifolin was proven to suppress the activity of the genes responsible for TGF-β1 expression, thus decreasing production of the proinflammatory cytokines and abrogated the inflammatory changes in the testicular microenvironment.⁴⁴

The interplay between the different pathways related to autophagy and apoptosis might represent the cornerstone in the pathophysiologic events that were observed in the gonads in response to prolonged exposure to BPA.⁴⁵ In the present work, rats treated with BPA exhibited significant decline in tissue p-MAPK and beclin-l with significant increase in tissue p-mTOR and p-AKT levels relative to the control group. This was in agreement with Anand et al.⁴⁶ who stated that there is an inverse relationship between the levels of p-mTOR and p-AKT on one hand and the expression of p-MAPK and beclin-l on the other hand. BPA was proven to enhance the activity of mTOR/AKT signaling pathways which in turn suppress the activity of MAP kinase enzyme.⁴⁷ This together with the resultant decrease in beclin-1 levels leads to defective autophagy.⁴⁸ In addition, modulation of mTOR/AKT/MAPK signaling in response to BPA administration was reported to enhance the expression of the proapoptotic proteins and decrement the tissue levels of the antiapoptotic molecules, particularly Bcl2.⁴⁵ This balance between autophagy and apoptosis was restored in the current study with administration of fluvastatin and/or taxifolin with induction of autophagy and decreased expression of the proapoptotic molecules. Cui et al.⁴⁹ attributed these events to the inhibitory effects that were exerted by fluvastatin on mTOR/AKT signaling which subsequently initiate the events that enhance autophagy and protect the testicular tissues from the pathogenic consequences of apoptosis. Also, Ponte et al.⁴¹ established a strong relation between taxifolin-mediated increase in beclin-1 and c-Jun N-terminal kinase and protection from the deleterious effects of apoptosis which coincided with the data obtained from the current work.

Ki-67 is one of the proliferation factors that are widely distributed in the body tissues, including the testis.⁵⁰ In the same line with the data obtained from the current study, it was reported that positive Ki-67 expression in the testis has a positive correlation with defective spermatogenesis in BPA-treated rats.²³ Also, positive Ki-67 expression was associated with extensive damage to the testicular architecture and induction of spermatogenic cell apoptotic pathways in rats.⁵¹ Moreover, increased Ki-67 expression induced by BPA administration was incriminated to be a major contributing factor to NF-κB mediated inflammation and apoptosis.⁵² These events were mitigated in the present study with administration of either fluvastatin or taxifolin, raising a high possibility that their protective effects against BPA-induced testicular dysfunction may be mediated, at least in part, via inhibition of Ki-67 expression with subsequent decrement of inflammation and apoptosis.^53,54

Fluvastatin/taxifolin combination given to rats treated with BPA in the current work elicited significant improvement of the body weight gain, hormonal profile, testicular morphometric measurements, sperm characteristics, the antioxidant status, and the anti-inflammatory mechanisms together with enhancement of autophagy and suppression of apoptosis in the testicular tissues relative to BPA-groups treated with either Fluvastatin or taxifolin alone. This may be explained, as illustrated in Figure 6, by the complementary effects of both agents on the ROS production, mTOR/AKT/MAPK signaling pathways together with their ability to combat BPA-induced activation of NLRP3 inflammasome which has an outstanding role in suppression of the proapoptotic pathways and induction of autophagy.

Figure 6.

Summary of the mechanisms by which fluvastatin and/or taxifolin might mitigate bisphenol A-induced testicular dysfunction.

P-glycoprotein is an efflux protein located in different tissues of the body including the gastrointestinal tract, brain, kidney and the gonads.⁵⁵ P-glycoprotein was reported to mediate resistance of the cells to certain members of statins, namely pravastatin and fluvastatin.⁵⁶ The synergistic effect encountered in the current work between taxifolin and fluvastatin may be explained by the ability of taxifolin to inhibit P-glycoprotein, thus facilitating entry and promoting the binding of fluvastatin to its target sites.⁵⁷ This together with the recent findings that taxifolin has a regulatory function on PPAR-γ pathway may add efficient anti-inflammatory and anti-apoptotic properties to fluvastatin.^58,59

Conclusion

Fluvastatin/taxifolin combination may provide a new remedy for combating the harmful effects of BPA on the gonadal functions in males. Attenuation of ROS production, modulation of autophagy, and apoptosis in addition to suppression of NLRP3 inflammasome are possible contributing mechanisms. Application of these findings in the clinical settings may significantly mitigate BPA-induced testicular toxicity in a large number of patients. Further studies are essentially needed to fully explore the molecular pathways that may contribute to these admirable effects and to evaluate the consequences of long-term administration of fluvastatin and/or taxifolin.

Footnotes

Acknowledgments

We greatly thank Taif University for providing fund for this work through Taif University Researcher Supporting Project number (TURSP-2020/52), Taif University, Taif, Saudi Arabia.

Authors contributions

Conceptualization: Ahmed M. Kabel; Methodology, Investigation, Formal analysis, Validation, Visualization: Ahmed M. Kabel, Samir A. Salama, Hany M. Borg, Dina A. Ali, Maaly A. Abd Elmaaboud; Funding Acquisition: Samir A. Salama; Writing- Original draft preparation: Ahmed M. Kabel; Writing- Reviewing and Editing: Ahmed M. Kabel.

Declaration of conflicting interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Taif University (TURSP-2020/52).

Data availability

Data used and/or analyzed during this study are available from the corresponding author upon reasonable request.

ORCID iD

Ahmed M Kabel Liu

References

Pjanic

. The role of polycarbonate monomer bisphenol-A in insulin resistance. PeerJ 2017; 5: e3809.

Jalal

Surendranath

Pathak

, et al. Bisphenol A (BPA) the mighty and the mutagenic. Toxicol Reports 2017; 5: 76–84.

Loffredo

Coden

Berdnikovs

. Endocrine disruptor bisphenol A (BPA) triggers systemic para-inflammation and is sufficient to induce airway allergic sensitization in mice. Nutrients 2020; 12: 343.

Adegoke

Rahman

Pang

M-G

. Bisphenols threaten male reproductive health via testicular cells. Front Endocrinol 2020; 11: 624.

Cimmino

Fiory

Perruolo

, et al. Potential mechanisms of bisphenol A (BPA) contributing to human disease. Int J Mol Sci 2020; 21: 5761.

Guo

Zhao

M-H

Shin

K-T

, et al. The possible molecular mechanisms of bisphenol A action on porcine early embryonic development. Scientific Rep 2017; 7: 8632.

Wen

Wang

, et al. Bisphenols and Leydig Cell Development and Function. Front Endocrinol 2020; 11: 447.

Vincze

Jenes

Füzi

, et al. Effects of fluvastatin and coenzyme Q10 on skeletal muscle in normo- and hypercholesterolaemic rats. J Muscle Res Cell Motil 2015; 36: 263–274.

Umeda

Takanari

Ogata

, et al. Direct free radical scavenging effects of water-soluble HMG-CoA reductase inhibitors. J Clin Biochem Nutr 2019; 64: 20–26.

10.

Gurel

Kuscu

Buhur

, et al. Fluvastatin attenuates doxorubicin-induced testicular toxicity in rats by reducing oxidative stress and regulating the blood-testis barrier via mTOR signaling pathway. Hum Exp Toxicol 2019; 38: 1329–1343.

11.

Liang

Shi

Xia

, et al. A novel ruthenium-fluvastatin complex downregulates SNCG expression to modulate breast carcinoma cell proliferation and apoptosis via Activating the PI3K/Akt/mTOR/VEGF/MMP9 Pathway. Oxidative Medicine Cellular Longevity 2021; 2021: 5537737.

12.

Salama

Kabel

. Taxifolin ameliorates iron overload-induced hepatocellular injury: Modulating PI3K/AKT and p38 MAPK signaling, inflammatory response, and hepatocellular regeneration. Chemico-Biological Interactions 2020; 330: 109230.

13.

Xie

Jiang

, et al. The mechanism of (+) taxifolin's protective antioxidant effect for OH-treated bone marrow-derived mesenchymal stem cells. Cell Mol Biol Lett 2017; 22: 31.

14.

Razak

Afsar

Ullah

, et al. Taxifolin, a natural flavonoid interacts with cell cycle regulators causes cell cycle arrest and causes tumor regression by activating Wnt/β -catenin signaling pathway. BMC Cancer 2018; 18: 1043.

15.

Chitra

Rao

Mathur

. Effect of bisphenol A and co-administration of bisphenol A and vitamin C on epididymis of adult rats: a histological and biochemical study. Asian Journal Andrology 2003; 5: 203–208.

16.

Hoscan*

Karabulut**

Hoscan

, et al. Oral fluvastatin reduces the severity of peritoneal adhesions in rats. Acta Chirurgica Belgica 2010; 110: 66–70.

17.

Bedir

Kocatürk

Yapanoğlu

, et al. Protective effect of taxifolin against prooxidant and proinflammatory kidney damage associated with acrylamide in rats. Biomed Pharmacother 2021; 139: 111660.

18.

Kabel

Salama

Alghorabi

, et al. Amelioration of cyclosporine‐induced testicular toxicity by carvedilol and/or alpha‐lipoic acid: Role of TGF‐β1, the proinflammatory cytokines, Nrf2/HO‐1 pathway and apoptosis. Clin Exp Pharmacol Physiol 2020; 47: 1169–1181.

19.

Wang

. Epididymal sperm count. Curr Protoc Toxicol 2003, Chapter 16Unit16.6.

20.

Babaei

Alizadeh-Fanalou

Nourian

, et al. Evaluation of testicular glycogen storage, FGF21 and LDH expression and physiological parameters of sperm in hyperglycemic rats treated with hydroalcoholic extract of Securigera Securidaca seeds, and Glibenclamide. Reprod Biol Endocrinol 2021; 19: 104.

21.

Johnsen

. Testicular Biopsy Score Count - A Method for Registration of Spermatogenesis in Human Testes: Normal Values and Results in 335 Hypogonadal Males. Horm Res Paediatrics 1970; 1: 2–25.

22.

Erfani Majd

Tabandeh

Hosseinifar

, et al. Protective Effect of Aloe vera Gel against Cisplatin-Induced Testicular Damage, Sperm Alteration and Oxidative stress in Rats. Int Journal Fertility Sterility 2021; 15: 210–218.

23.

Zhao

W-P

Wang

H-W

Liu

, et al. Positive PCNA and Ki-67 Expression in the Testis Correlates with Spermatogenesis Dysfunction in Fluoride-Treated Rats. Biol Trace Elem Res 2018; 186: 489–497.

24.

Pratap

Gupta

Bhardwaj

, et al. Resin based restorative dental materials: characteristics and future perspectives. Jpn Dental Sci Rev 2019; 55: 126–138.

25.

Liu

, et al. The adverse health effects of bisphenol A and related toxicity mechanisms. Environ Res 2019; 176: 108575.

26.

Barbagallo

Condorelli

Mongioì

, et al. Effects of bisphenols on testicular steroidogenesis. Front Endocrinol 2020; 11: 373.

27.

Santiago

Silva

Santos

MAS

, et al. Fighting Bisphenol A-Induced male infertility: the power of antioxidants. Antioxidants 2021; 10: 289.

28.

Meli

Monnolo

Annunziata

, et al. Oxidative stress and BPA toxicity: an antioxidant approach for male and female reproductive dysfunction. Antioxidants 2020; 9: 405.

29.

Rahman

Pang

M-G

. Understanding the molecular mechanisms of bisphenol A action in spermatozoa. Clin Exp Reprod Med 2019; 46: 99–106.

30.

Alboghobeish

Mahdavinia

Zeidooni

, et al. Efficiency of naringin against reproductive toxicity and testicular damages induced by bisphenol A in rats. Iranian Journal Basic Medical Sciences 2019; 22: 315–523.

31.

Ramanjaneyulu

Trivedi

Kushwaha

, et al. Protective role of atorvastatin against doxorubicin-induced cardiotoxicity and testicular toxicity in mice. J Physiology Biochemistry 2013; 69: 513–525.

32.

Hwang

A-R

Han

J-H

Lim

, et al. Fluvastatin inhibits AGE-induced cell proliferation and migration via an ERK5-dependent Nrf2 pathway in vascular smooth muscle cells. PLoS One 2017; 12: e0178278.

33.

Shubina

Shatalin

. Antioxidant and iron-chelating properties of taxifolin and its condensation product with glyoxylic acid. J Food Sci Tech 2017; 54: 1467–1475.

34.

Wang

Yang

Luo

, et al. Bisphenol A increases TLR4-mediated inflammatory response by up-regulation of autophagy-related protein in lung of adolescent mice. Chemosphere 2021; 268: 128837.

35.

Banerjee

Das

Paul

, et al. Mechanistic study of attenuation of monosodium glutamate mixed high lipid diet induced systemic damage in rats by Coccinia grandis. Scientific Rep 2020; 10(1): 15443.

36.

Banerjee

Mukherjee

Maji

. Worldwide flavor enhancer monosodium glutamate combined with high lipid diet provokes metabolic alterations and systemic anomalies: An overview. Toxicol Rep 2021; 8: 938–961.

37.

Alyaseer

AAA

de Lima

MHS

Braga

. The Role of NLRP3 inflammasome activation in the epithelial to mesenchymal transition process during the fibrosis. Front Immunol 2020; 11: 883.

38.

Wang

Zhang

Xiao

, et al. NLRP3 inflammasome and inflammatory diseases. Oxidative Medicine Cellular Longevity 2020; 2020: 4063562.

39.

Wang

Xie

Lei

, et al. Statins attenuate activation of the NLRP3 inflammasome by oxidized LDL or TNFα in vascular endothelial cells through a PXR-Dependent mechanism. Mol Pharmacol 2017; 92: 256–264.

40.

Yang

C-C

C-H

Lin

T-C

, et al. Inhibitory effect of PPARγ on NLRP3 inflammasome activation. Theranostics 2021; 11: 2424–2441.

41.

Ponte

LGS

Pavan

ICB

Mancini

MCS

, et al. The hallmarks of flavonoids in cancer. Molecules 2021; 26: 2029.

42.

Kabel

Arab

Abd Elmaaboud

. Attenuation of diethyl nitrosamine-induced hepatocellular carcinoma by taxifolin and/or alogliptin: The interplay between toll-like receptor 4, transforming growth factor beta-1, and apoptosis. Hum Exp Toxicol 2021: 9603271211008496.

43.

Muramatsu

Uchiyama

Kida

, et al. Cell cytotoxity and anti-glycation activity of taxifolin-rich extract from Japanese larch, Larix kaempferi. Heliyon 2019; 5: e02047.

44.

Ren

Guo

H-N

Yang

, et al. Dissecting efficacy and metabolic characteristic mechanism of taxifolin on renal fibrosis by multivariate approach and ultra-performance liquid chromatography coupled with mass spectrometry-based metabolomics strategy. Front Pharmacol 2021; 11: 608511.

45.

Quan

Wang

Duan

, et al. Bisphenol a induces autophagy and apoptosis concurrently involving the Akt/mTOR pathway in testes of pubertal SD rats. Environ Toxicol 2017; 32: 1977–1989.

46.

Anand

Sharma

Singh

, et al. Activation of autophagic flux via LKB1/AMPK/mTOR axis against xenoestrogen Bisphenol-A exposure in primary rat hepatocytes. Food Chem Toxicol 2020; 141: 111314.

47.

Lin

F-J

, et al. Non-alcoholic fatty liver disease induced by perinatal exposure to bisphenol a is associated with activated mTOR and TLR4/NF-κB signaling pathways in offspring rats. Front Endocrinol 2019; 10: 620.

48.

Priego

Parra

Mas

, et al. Bisphenol A modulates autophagy and exacerbates chronic kidney damage in mice. Int J Mol Sci 2021; 22: 7189.

49.

Cui

Long

Zhu

, et al. Protective effects of fluvastatin on reproductive function in obese male rats induced by High-fat diet through enhanced signaling of mTOR. Cell Physiol Biochem 2017; 41: 598–608.

50.

Matsubara

Mukai

Fujii

, et al. Different prognostic significance of Ki-67 change between pre- and post-neoadjuvant chemotherapy in various subtypes of breast cancer. Breast Cancer Res Treat 2013; 137: 203–212.

51.

Sukhorum

Iamsaard

. Changes in testicular function proteins and sperm acrosome status in rats treated with valproic acid. Reprod Fertil Dev 2017; 29: 1585–1592.

52.

Kim

C-H

Kim

Park

, et al. Bisphenol A exposure changes the transcriptomic and proteomic dynamics of human retinoblastoma Y79 Cells. Genes 2021; 12: 264.

53.

Garwood

Kumar

Baehner

, et al. Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer. Breast Cancer Res Treat 2010; 119: 137–144.

54.

Wang

Zhu

Wang

, et al. The anti-tumor effect of taxifolin on lung cancer via suppressing stemness and epithelial-mesenchymal transition in vitro and oncogenesis in nude mice. Ann Translational Med 2020; 8: 590–590.

55.

Callaghan

Luk

Bebawy

. Inhibition of the multidrug resistance P-glycoprotein: time for a change of strategy? Drug Metab Disposition 2014; 42: 623–631.

56.

Goard

Mather

Vinepal

, et al. Differential interactions between statins and P-glycoprotein: implications for exploiting statins as anticancer agents. Int J Cancer 2010; 127: 2936–2948.

57.

Das

Baidya

Chakraborty

, et al. Pharmacological basis and new insights of taxifolin: a comprehensive review. Biomed Pharmacother 2021; 142: 112004.

58.

, et al. Taxifolin attenuates the developmental testicular toxicity induced by di-n-butyl phthalate in fetal male rats. Food Chem Toxicol 2020; 142: 111482.

59.

Zhai

Zhao

, et al. Taxifolin inhibits keratinocyte proliferation and ameliorates imiquimod-induced psoriasis-like mouse model via regulating cytoplasmic phospholipase A2 and PPAR-γ pathway. Int Immunopharmacology 2021; 99: 107900.

Targeting p-AKT/mTOR/MAP kinase signaling,NLRP3 inflammasome and apoptosis by fluvastatin with or without taxifolin mitigates gonadal dysfunction induced by bisphenol-A in male rats

Abstract

Keywords

Introduction

Materials and methods

Chemicals and reagents

Experimental animals

Experimental protocol

Harvesting the blood and tissue samples

Measurement of the hormonal profile

Assay of the markers of the testicular functions

Assay of the antioxidant enzymes, nuclear factor erythroid 2-related factor 2 (Nrf2), and heme oxygenase-1 (HO-1) content in the testicular tissues

Assay of transforming growth factor beta 1 (TGF-β1), interleukin 8 (IL-8), interleukin 18 (IL-18), and nucleotide-binding domain-like receptor family, pyrin domain-containing 3 (NLRP3) inflammasome in the testicular tissues

Determination of testicular tissue phospho-mTOR, phosphoprotein kinase B (p-AKT), p38 mitogen-activated protein (p-MAP) kinase and beclin-1 levels

Assay of the apoptotic markers in the testicular tissues

Determination of the characteristics of the spermatozoa

Histopathological evaluation of the testicular tissues

Evaluation of the expression of Ki-67 in the testicular tissues

Statistical analysis of the results

Results

Fluvastatin and/or taxifolin improved the body weight gain in BPA-treated animals

Fluvastatin and/or taxifolin combatted the hormonal changes induced by BPA

Fluvastatin and/or taxifolin restored the markers of testicular functions to the normal values compared to PBA-treated animals

Fluvastatin and/or taxifolin improved the antioxidant status and mitigated the changes in Nrf2/HO-1 content in BPA-treated animals

Fluvastatin and/or taxifolin abrogated the changes related to the inflammatory cascade induced by BPA in the testicular tissues

Fluvastatin and/or taxifolin enhanced the autophagy-associated pathways in the testicular tissues of the studied groups

Fluvastatin and/or taxifolin significantly combatted the apoptotic changes induced by BPA in the testicular tissues

Fluvastatin and/or taxifolin mitigated the changes in the characteristics of the spermatozoa induced by BPA

Fluvastatin and/or taxifolin combatted the changes in the testicular morphometric characteristics and JTBS induced by BPA

Fluvastatin and/or taxifolin mitigated the increase in Ki-67 immunoexpression induced by BPA in the testicular tissues

Discussion

Conclusion

Footnotes

Acknowledgments

Authors contributions

Declaration of conflicting interests

Funding

Data availability

ORCID iD

References